S.No. |
Sex |
Age (Years) |
Therapy |
Laterality |
Differentiation |
High risk |
p53 |
Mdm2 |
1 |
Female |
3 |
No |
Unilateral |
Poorly |
High risk |
2 |
- |
2 |
Male |
0.3 |
No |
Unilateral |
Poorly |
- |
- |
- |
3 |
Female |
5 |
No |
Bilateral |
Poorly |
High risk |
- |
- |
4 |
Female |
5 |
No |
Unilateral |
Poorly |
- |
2 |
1 |
5 |
Female |
1.5 |
No |
Unilateral |
Poorly |
- |
- |
1 |
6 |
Female |
3 |
No |
Unilateral |
Poorly |
High risk |
- |
1 |
7 |
Female |
4 |
chemo |
Bilateral |
Poorly |
- |
- |
- |
8 |
Male |
4.5 |
No |
Bilateral |
Poorly |
- |
1 |
- |
9 |
Female |
1 |
No |
Unilateral |
Well |
- |
- |
- |
10 |
Female |
1 |
No |
Unilateral |
Well |
- |
2 |
- |
11 |
Female |
3 |
No |
Unilateral |
Poorly |
- |
- |
1 |
12 |
Male |
7 |
No |
Bilateral |
Poorly |
High risk |
- |
1 |
13 |
Female |
5 |
No |
Unilateral |
Poorly |
High risk |
- |
- |
14 |
Male |
4 |
chemo |
Unilateral |
Poorly |
High risk |
- |
1 |
15 |
Female |
3 |
No |
Unilateral |
Poorly |
High risk |
2 |
- |
16 |
Male |
5 |
No |
Bilateral |
Poorly |
High risk |
- |
1 |
17 |
Male |
0.1 |
No |
Unilateral |
Poorly |
High risk |
1 |
- |
18 |
Male |
0.3 |
No |
Bilateral |
Poorly |
High risk |
- |
1 |
19 |
Female |
3 |
No |
Unilateral |
Poorly |
High risk |
- |
1 |
20 |
Male |
4 |
chemo |
Unilateral |
Poorly |
- |
- |
- |
21 |
Male |
0.75 |
chemo |
Bilateral |
Well |
- |
- |
- |
22 |
Male |
2 |
No |
Unilateral |
Poorly |
- |
1 |
1 |
23 |
Male |
0.3 |
No |
Unilateral |
Well |
- |
- |
- |
24 |
Male |
2 |
No |
Bilateral |
Well |
- |
- |
- |
25 |
Female |
1.5 |
No |
Unilateral |
Poorly |
High risk |
- |
1 |
26 |
Male |
3 |
No |
Unilateral |
Poorly |
High risk |
- |
1 |
27 |
Male |
6 |
No |
Unilateral |
Poorly |
- |
- |
1 |
28 |
Male |
2.5 |
No |
Unilateral |
Well |
- |
- |
- |
29 |
Male |
6 |
No |
Bilateral |
Poorly |
High risk |
1 |
- |
30 |
Female |
5 |
No |
Unilateral |
Poorly |
High risk |
- |
- |
31 |
Male |
5 |
chemo |
Unilateral |
Poorly |
High risk |
- |
- |
32 |
Male |
0.75 |
chemo |
Unilateral |
Poorly |
High risk |
1 |
- |
33 |
Male |
4 |
No |
Bilateral |
Poorly |
High Risk |
- |
2 |
34 |
Male |
1.5 |
No |
Bilateral |
Poorly |
High risk |
- |
- |
35 |
Male |
6 |
No |
Unilateral |
Poorly |
High risk |
- |
- |
36 |
Female |
2.5 |
No |
Unilateral |
Poorly |
High risk |
1 |
- |
37 |
Male |
1 |
No |
Unilateral |
Poorly |
- |
- |
- |
38 |
Female |
3.5 |
chemo |
Unilateral |
Poorly |
- |
- |
- |
39 |
Male |
0.5 |
No |
Bilateral |
Poorly |
High risk |
- |
2 |
40 |
Female |
1.5 |
No |
Unilateral |
Poorly |
- |
- |
- |
41 |
Male |
1.3 |
No |
Unilateral |
Poorly |
High risk |
- |
- |
42 |
Male |
1 |
No |
Bilateral |
Poorly |
High risk |
1 |
- |
43 |
Male |
4 |
No |
Bilateral |
Well |
High risk |
2 |
1 |
44 |
Female |
2.5 |
No |
Bilateral |
Poorly |
High risk |
1 |
- |
45 |
Female |
3 |
No |
Bilateral |
Poorly |
- |
- |
- |
46 |
Male |
5 |
No |
Unilateral |
Poorly |
High risk |
1 |
- |
47 |
Female |
1.5 |
No |
Unilateral |
Well |
High risk |
- |
1 |
48 |
Male |
0.5 |
No |
Unilateral |
Poorly |
High risk |
1 |
- |
49 |
Male |
6 |
chemo |
Unilateral |
Poorly |
- |
- |
1 |
50 |
Male |
3 |
chemo |
Bilateral |
Poorly |
High risk |
- |
- |
51 |
Male |
1.5 |
No |
Bilateral |
Poorly |
High risk |
- |
- |
52 |
Male |
2.5 |
No |
Bilateral |
Poorly |
- |
1 |
- |
53 |
Male |
2.5 |
No |
Bilateral |
Poorly |
High risk |
- |
- |
54 |
Male |
0.5 |
chemo |
Unilateral |
Poorly |
High risk |
1 |
1 |
55 |
Male |
2.5 |
chemo |
Unilateral |
Poorly |
High risk |
1 |
1 |
56 |
Male |
2 |
No |
Unilateral |
Poorly |
High risk |
1 |
- |
57 |
Male |
7 |
chemo |
Unilateral |
Poorly |
High risk |
1 |
2 |
58 |
Male |
0.3 |
chemo |
Bilateral |
Poorly |
- |
- |
- |
59 |
Female |
1.2 |
No |
Unilateral |
Poorly |
High risk |
2 |
- |
60 |
Female |
2 |
No |
Unilateral |
Poorly |
- |
- |
- |
|
